Esbriet Extends Survival Rates Among People with IPF by 30%

  • This topic has 1 voice and 0 replies.
Viewing 0 reply threads
  • Author
    Posts
    • #15727

      Esbriet (pirfenidone) can improve survival rates of people with idiopathic pulmonary fibrosis by 30 percent, a real-world analysis shows. Learn more here.

      Are you being/have you been treated with Esbriet? How do you feel about this news?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2020 All rights reserved.

©2020 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account